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1090 Brussels, BelgiumReceived 18 July 2005; accepted 18 July 2005Summary PTCH gene is well-known to be responsible for the development of Gorlin
syndrome. It is also believed that PTCHmutation is responsible for the developmental
of odontogenic keratocysts both in the Gorlin syndrome related and the sporadic
cases. There is a conflict opinion in the literature regarding its role in odontogenic
cysts. Furthermore, it is not knownwhether PTCH expression has any relevant clinical
role in the outcome of the odontogenic cysts. In this study 8 odontogenic keratocysts,
16 dentigerous cysts and 23 radicular cysts treated in the academic hospital of the
Free University of Brussels were subjected to an immunohistochemistry study for
their expression of PTCH. The data obtained were linked to the clinical behaviour
of the cysts for a follow-up of up to 20 years. Eighty eight percent of the odontogenic
keratocysts (OKC), 67% of dentigerous cysts, (DC) and only 25% of radicular cysts (RC)
expressed PTCH. This difference was statistically significant. Seventeen patients
could be called back for clinical evaluation, the follow-up ranged from 10 to 20 years.
Four patients suffering fromOKC had clinical complications, 3 in the DC group and 2 in
the RC group. Complications ranged from (multiple) recurrence to one case of trans-
formation into an ameloblastoma. Only one patient suffered from clinical complica-
tion of a RC without being PTCH positive. One patient who had a PTCH negative DC
and seven patients with PTCH negative RC had no clinical complications. The results
indicate that PTCH expression in odontogenic cysts is more likely to be the reason of
clinical complication rather than a cause of pathogenesis.c 2005 Elsevier Ltd. All rights reserved.
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In 1996 the gene responsible for Gorlin syndrome
(an inherited condition that causes unusual facialved.
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system, eyes, and endocrine glands. Also called
basal cell nevus syndrome) was discovered1
namely PTCH gene. PTCH is a trans-membrane
receptor which binds to Sonic hedgehog (SHH) pro-
tein to form a complex compound.2 PTCH expres-
sion is intended to down-regulate and stop the
signaling triggered by the arrival of the SHH se-
creted protein at the cell membrane.3,4 This
auto-regulating PTCH role, which ensures limited
programmed proliferation, fails if the gene is
altered by mutations or deletions. The result is
uncontrolled cell proliferation, as well as a contin-
uous and useless synthesis of the non-functional
PTCH protein.1–5
Several studies focused on this gene function in
odontogenic keratocysts both sporadic and syn-
drome related.1,6–8 The result of these studies
was that in Gorlin syndrome a predisposing muta-
tion is already present in the germ line and only a
single mutational event is required in the somatic
cell to cause homozygous inactivation and neoplas-
tic progression, whereas in sporadic cysts two inde-
pendent mutational events are required in the
somatic cell.7,8
Lench et al. thought it possible that the OKC
represented one of the first clinical manifestations
of homozygous inactivation of the PTCH gene,12 at
that time named NBCCS.
After this discovery some authors investigated
whether PTCH was responsible for the developing
of sporadic odontogenic keratocysts.
Levanat et al.6 studied 6 syndrome cysts and 14
sporadic cysts. They found that each syndrome cyst
retained the mutant allele and lost the allele from
the unaffected parent. In sporadic cysts two muta-
tions hits were observed in PTCH gene in somatic
cells. They were confident that there was a clear
relationship between the observed molecular
change (PTCH mutation) and the developmental
defect.6
In 2000 Barreto et al.7 studied PTCH mutation in
6 odontogenic keratocysts, three of them were
sporadic cases. They concluded that PTCH has a
major role in the formation of sporadic and Gorlin
syndrome associated odontogenic keratocysts.7
To that stage of the research, the above men-
tioned authors believed that PTCH mutation is
responsible for the developmental of odontogenic
keratocysts both in the Gorlin syndrome related
and the sporadic cases. By 2001 an antibody for
PTCH was commercially available allowing its rou-
tine application in immunohistochemical studies
on odontogenic cysts.
PTCH is only expressed during the embryonic
development,2–4 later on it is downregulated andits expression is not detected. As all the known
mutations in PTCH affect the function but not the
stability of its protein;4,5 we believe that this anti-
body detects mainly the mutant PTCH in adult
tissue.
Few years ago the theory of PTCH and its rela-
tion to odontogenic keratocysts was extended to
another developmental cyst type: the dentigerous
cysts.
Barreto et al.8 applied this antibody to 15 radic-
ular cysts, 29 odontogenic keratocysts, and 6 den-
tigerous cysts. It is interesting that their study
revealed the presence of PTCH protein in virtually
all cysts.8 Pavelic et al.9 investigated the expres-
sion of PTCH in 10 odontogenic keratocysts, 10
dentigerous cysts and 10 radicular cysts. By study-
ing PTCH–RNA and protein expression they found
no activity for PTCH in radicular cysts while this
expression was strongly observed in odontogenic
keratocysts and dentigerous cysts. In the contrast
to the previous authors the main conclusion was
that PTCH is responsible for the developing of
OKS and DC, and that it is not related to radicular
cysts.9
To summarize: Up-to-date the literature gives a
conflicting view regarding the role of PTCH expres-
sion in odontogenic cysts, as some authors believe
that PTCH is the main pathogenesis of all odonto-
genic cysts while others believe that it is involved
in the pathogenesis of developmental cysts only
and not related to radicular cysts.
Trying to solve this conflict and uncover the role
of PTCH in the pathogenesis of odontogenic cysts
we applied PTCH antibody to samples of the three
major types of odontogenic cysts. Furthermore, we
tried to investigate the relation (if exists) between
PTCH expression and the clinical outcome.Material and methods
All samples of odontogenic keratocysts and den-
tigerous cysts treated in the VUB university hospi-
tal until 1995 were included in this study. The
group consisted of 8 odontogenic keratocysts and
16 dentigerous cysts. Twenty-three radicular
cysts were selected to match for gender, age
and anatomical location of the developmental
odontogenic cysts. Paraffin blocks were retrieved
from the pathology department archive. New
H&E slides were made to confirm the diagnosis.
After re-evaluating the cases there was no single
new diagnosis for any of the examined cases,
and the original histopathological diagnosis was
kept.
Figure 1 Moderate intensity positivity in an odonto-
genic keratocysts.
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surgery patients were included to the study sam-
ple as negative control. All samples were formalin
or boin fixed tissue embedded in paraffin. All the
cysts were treated in the head and neck surgery
department, academic hospital of the Free Uni-
versity of Brussels during the period 1982–1995.
The gingival samples were obtained from peri-
odontal surgery patients treated in the clinics of
dentistry institute of the Free University of
Brussels. This sample (cysts and gingivas) was sub-
jected to PTCH antibody through immunohisto-
chemistry.
Cysts patients were called back for clinical eval-
uation, each patient we could reach was asked to
answer a questionnaire regarding his/her general
and dental health, whether or not he/she had had
complications in the cyst site.
On the same appointment date the patient
underwent clinical evaluation in the dentistry insti-
tute clinic or in the stomatology department’s out-
patient clinic. This evaluation focused on the area
of the previous lesion and mainly whether or not
there was any fistula, chronic swelling, resistant
pain or uncomfortable sensation in the jaw or the
covering mucosa.
Lastly, a panoramic radiograph was taken for
each patient to see the eventual recovery of the
operation site, or to detect any recurrence or other
suspicious lesion in the same area.
Immunohistochemistry procedure: Slides of
5 lm were sectioned, washed in xylol two times
for 5 min followed by dehydration in an alcohol ser-
ies. Antigen unmasking was done by immersing the
slides in 6 M urea in a microwave oven till boiling
followed by cooling down to room temperature
for 20 min. Blocking peroxidase was achieved by
3% H2O2 in PBS for 10 min. The primary antibody
(PTCH antibody, Santa Cruz, sc-6149) of 1:200
was applied over night at 4. Negative controls
incubated in BSA 1% under similar conditions. The
secondary antibody was applied for 30 min in
room temperature in a dilution of 1:500. Then
slides were incubated in DAB for 10 min. Between
each step the slides were rinsed in PBS two times
for 3 min. Slides were then alcohol dried and
mounted.
As negative control each sample was subjected
to the identical procedure with the exception of
the addition of the primary antibody.
Microscopic evaluation methods: The black
spots in the cytoplasma of the epithelial lining cells
of the cysts were detected as the positive sign of
the antibody. All cysts were studied under low
magnification (40·) using standard light microscopy
(Zeiss, Germany).Results
No positivity was detected in all negative control.
When positivity was detected the intensity differed
from cysts to another and ranged from moderate
intensity (Fig. 1) to high intensity (Fig. 2), but it
was neglected and all positive cases were judged
as positive cases regardless from the positivity
intensity. In positive cases positivity was shown in
all the cell layers of the epithelial lining of odonto-
genic cysts. All gingival samples were completely
negative for PTCH antibody. Seven out of the odon-
togenic keratocysts expressed PTCH (88%), 11 den-
tigerous cysts (67%) and only 6 radicular cysts (25%)
(Table 1). This difference was statistically signifi-
cant with a p value less than 0.05% according to
the v2-test.
Table 1 Immunohistochemistry study results
PTCH
positive
PTCH
negative
Odontogenic keratocysts 7 1
Dentigerous cysts 11 5
Radicular cysts 6 17
Table 2 Follow-up study results
Clinical
complication
No clinical
complication
PTCH + PTCH  PTCH + PTCH 
OKC 4 – – –
DC 3 – – 1*
RC 2 1 – 7
* Case of a fourth molar.
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evaluation of their dental health, they represent 4
OKC, 4 DC and 10 RC. The follow-up ranged from 10
to 20 years. Follow-up study relieved some cases
that suffered from (multiple) recurrence or neo-
plastic transformation; these cases were scored
as the clinical complication cases (Table 2).
Four patients suffering from OKC had clinical
complications, 3 in the DC group and 2 in the RC
group. Complications ranged from (multiple) recur-
rence to one case of transformation into an amelo-
blastoma. The neoplastic transformation case
occurred in a radicular cyst that was treated
15 years ago. Only one patient suffered from clini-
cal complication of a RC without being PTCH posi-
tive. One patient had a PTCH negative DC without
clinical complication, in fact this dentigerous cysts
was attached to an impacted fourth molar. Seven
patients with PTCH negative RC had no clinical
complications.
Although the small sample of follow-up study did
not allow a thorough statistical evaluation, still it is
clear that only two patients suffered from clinical
complication without being PTCH positive.Discussion and conclusion
Since Johnson et al.1 reported that PTCH gene is
a candidate gene for the basal cell nevus syn-
drome (BCNS), also called Gorlin syndrome, other
abnormalities were linked to mutation and/orover-expression of PTCH in conditions such as
colonic neoplasia,10 odontogenic keratocysts11
and ameloblastomas.4,5
Later on some authors suggested that expression
of the tumour suppressor PTCH and the oncogene
Shh may cause loss of PTCH function and so lead
to OKC development6–8 by stimulating continuous
proliferation of dental lamina cells instead of their
normal degeneration.
Moreover, some authors suggested that PTCH
plays a major role in odontogenic cysts formation.
They stated that PTCH is responsible for the forma-
tion of dentigerous cysts and not only of odonto-
genic keratocysts. In the same article the authors
found no expression of PTCH in their radicular cysts
sample and stated that this subtype of cysts may
have a different pathogenesis that is not related
to PTCH.11
In contrast to this, another study releaved that
PTCH expression is detectable in all odontogenic
cysts including radicular cysts,10 and so PTCH might
be the major cause for the pathogenesis of odonto-
genic cysts.
Our results show that all major subtypes of
odontogenic cysts might express PTCH. Still 88%
of odontogenic keratocysts are PTCH positive, the
percentage drops to 67% of dentigerous cysts and
reach only 25% of radicular cysts. Factors as the fix-
ation method and duration, of historical patholog-
ical samples should be taken into account for
differences in staining pattern. Other lab proce-
dures such as antigen retrieval technique may also
interfere with the results and quality of immuno-
histochemistry. Finally, and on top small sample
size that is generally used to study gene expression
in odontogenic cysts might raise the risk of over or
down estimating any observation. Still we believe
that our results indicate that PTCH is not the only
pathogenesis factor in odontogenic cysts; although
it plays a major role in their pathogenesis espe-
cially the developmental odontogenic cysts. As
not all the odontogenic cysts express PTCH, it is
an over-conclusion to state that PTCH is the main
reason for the origin of odontogenic cysts or any
of its subtypes as proposed by Barreto et al.8 and
Pavelic et al.9
Due to the fact that only small number of pa-
tients answered our call back, which is a limitation
of any retrospective study, still almost all the cases
(90%) that expressed PTCH had gave a sort of clin-
ical complication in a follow-up of 10–20 years.In
the light of the clinical follow-up this might indi-
cate that PTCH expression in odontogenic cysts is
more likely to be the reason of clinical complica-
tion rather than a cause of pathogenesis.
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